Plasma Malondialdehyde Levels and Risk Factors for the Development of Chronic Complications in Type 2 Diabetic Patients on Insulin Therapy - Concepedia

Concepedia

Publication | Closed Access

Plasma Malondialdehyde Levels and Risk Factors for the Development of Chronic Complications in Type 2 Diabetic Patients on Insulin Therapy

29

Citations

0

References

2012

Year

Michelle Kaefer, Jos A. M. De Carvalho, Slvia J. Piva, Dievan B. Da Silva, Aline Minuzzi Becker, Manuela B. Sangoi, Tas C. Almeida, Carine Lima Hermes, Adriane C. Coelho, Raquel Tonello,

Clinical Laboratory

Abstract

MDA levels increased in type 2 diabetes, especially in patients on insulin therapy. Chronic hyperglycemia and other biomarkers, such as urinary albumin, were correlated with MDA levels, suggesting the involvement of lipid peroxidation in the pathogenesis of diabetes complications.